Research - Düsseldorf, North Rhine-Westphalia, Germany
Diagreat is a high-tech enterprise specializing in developing, manufacturing and distributing of IVD (In Vitro Diagnosis) reagents, analyzers and raw materials. Leading R&D technology There are more than 100 people in our R&D team, which includes 8 PHD staff and a number of Master staff who owns more than 10 patents. Our team has completed over 50 kinds of IVD products innovation. Other than this, there are a number of products under innovation and clinical testing. The rich-experience R&D team is the base stone of Diagreat innovation. Complete R&D Platforms Our company consists kinds of different platforms, including Genetic engineering platform, protein expression, purification, biological enzyme preparation test platform, monoclonal antibodies, polyclonal antibody platform, nanometer microspheres, biochemical enzymes reagent R&D platform, turbidimetric reagent R&D platform, chromatography reagents development platform, homogeneous immune reagent R&D platform and so on more than 10 biochemical, immune and POCT reagents related R&D technology platform. Multiple kinds of productsBased on the whole chain of R&D and manufacturing line, Diagreat not only focuses on the clinical IVD test, but also offers other companies technological service and provide OEM packages. Diagreat owns a rich-experience R&D team which leads us to have the ability to keep going ahead and develop new products continuously. In the quality control aspect, Diagreat obeys the rules of GMP and all of our products have been certificated by ISO9001, ISO13485 and EQA plan.
ASP.NET
Microsoft-IIS
DNSPod
Mobile Friendly